Skip to content

Clinical trials

Terminated Mental Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Status: Terminated Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20161
20171
20184
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Affiris AG1
Centre Hospitalier Intercommunal Creteil1
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer1
GlaxoSmithKline1
Hoffmann-La Roche1
Nantes University Hospital1
University Hospital, Montpellier1
University Hospital, Toulouse1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders11
Alzheimer Disease7
Brain Diseases6
Dementia6
Nervous System Diseases6
Central Nervous System Diseases5
Tauopathies5
Neurodegenerative Diseases4
Neurocognitive Disorders3
Anxiety Disorders1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.